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Two-photon dual imaging platform 
for in vivo monitoring cellular 
oxidative stress in liver injury
Haolu Wang1,2, Run Zhang3, Kim R. Bridle4, Aparna Jayachandran4, James A. Thomas5, 
Wenzhu Zhang6, Jingli Yuan6, Zhi Ping Xu3, Darrell H. G. Crawford4, Xiaowen Liang1, Xin Liu1 & 
Michael S. Roberts1,7
Oxidative stress reflects an imbalance between reactive oxygen species (ROS) and antioxidants, which 
has been reported as an early unifying event in the development and progression of various diseases 
and as a direct and mechanistic indicator of treatment response. However, highly reactive and short-
lived nature of ROS and antioxidant limited conventional detection agents, which are influenced by 
many interfering factors. Here, we present a two-photon sensing platform for in vivo dual imaging of 
oxidative stress at the single cell-level resolution. This sensing platform consists of three probes, which 
combine the turn-on fluorescent transition-metal complex with different specific responsive groups for 
glutathione (GSH), hydrogen peroxide (H2O2) and hypochlorous acid (HOCl). By combining fluorescence 
intensity imaging and fluorescence lifetime imaging, these probes totally remove any possibility of 
crosstalk from in vivo environmental or instrumental factors, and enable accurate localization and 
measurement of the changes in ROS and GSH within the liver. This precedes changes in conventional 
biochemical and histological assessments in two distinct experimental murine models of liver injury. 
The ability to monitor real-time cellular oxidative stress with dual-modality imaging has significant 
implications for high-accurate, spatially configured and quantitative assessment of metabolic status 
and drug response.
Oxidative stress has been reported as an early unifying event in the development and progression of various dis-
eases including injury1,2, cancer3, and many inflammatory diseases4. It reflects an imbalance between the produc-
tion of reactive oxygen species (ROS) and antioxidant defenses, such as glutathione (GSH)5. Excessive production 
of ROS damages all components of the cell, including lipids, proteins, and DNA. Some ROS, including hydrogen 
peroxide (H2O2) and hypochlorous acid (HOCl), also act as cellular messengers, and can cause disruptions in 
normal mechanisms of cellular signaling5. While GSH, the major ROS-scavenging system in cells to reduce ROS 
stress, can detoxify the reactive intermediates and repair the resulting damage. Because ROS and antioxidants 
have distinct sources of production and are particularly sensitive to upstream molecular interventions6, their 
detection at the single cell-level resolution could be useful for identifying subpopulations of cells with different 
susceptibility to ROS-induced injury in different stages of diseases. Moreover, the oxidative stress endpoints can 
report early and molecular changes due to treatment7, and have potential to serve as powerful biomarkers of 
drug response. For example, in liver diseases, the primary endpoint of drug efficacy is functional recovery of 
hepatocytes. The current treatment evaluations include imaging liver morphology, monitoring blood levels of 
liver enzymes, bilirubin and markers of inflammation, and assessing the signs and symptoms8. Yet each of these 
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current techniques fails to capture dynamic changes in metabolic state and poorly reflects sensitivity to drug effi-
cacy. Cellular and molecular changes of hepatocytes precede changes in liver morphology or markers in periph-
eral blood during treatment. If these molecular endpoints can be identified and measured, they would provide 
powerful biomarkers for early-drug response.
Methods to detect oxidative stress in vivo have encountered technical challenges, which prevented imple-
mentation of this method for preclinical drug efficacy screening2,9. A number of GSH and ROS-detection probes 
have been developed9–13. Most of them are single-mode intensity-based probes, which can provide quantitative 
results, but may often be influenced by fluid optical properties, endogenous fluorophores, probe concentration, 
and other in vivo environmental or instrumental factors. The fluorescence lifetime of probes are independent of 
these interfering factors, offering accurate and ultrasensitive detecting the presence of many components of cell 
signaling pathways14–16. Thus, the combination of fluorescence intensity imaging and fluorescence lifetime imag-
ing (FLIM) is an ideal procedure for intracellular oxidative stress investigations with high reliability and accuracy. 
Up to now, however, no such dual-mode probe has been developed for in vivo real-time molecular imaging. We 
have previously synthesized a transition-metal complex-based sensing platform for detecting cellular GSH and 
ROS levels in vitro17–20. This sensing platform consists of three probes, which exhibit favorable photophysical 
properties including high photostability, selective and quantitative response. To further investigate the fluores-
cence lifetime and two-photon absorption behavior of this platform, and advance to monitoring multiple analytes 
at the single cell-level resolution in living systems, here we combined fluorescence intensity imaging and FLIM 
to detect oxidative stress in the liver of living mice using this sensing platform. We investigated this approach as 
a tool for monitoring cellular oxidative stress to predict drug response in two of the most common types of liver 
injury: acetaminophen (APAP)-induced liver injury, which accounts for approximately one-half of all acute liver 
failures in the western world today21, and hepatic ischemia-reperfusion (I/R) injury, which often occurs during 
liver resection and liver transplantation22. The drug response predicted by cellular oxidative stress was further 
compared with alanine aminotransferase (ALT) levels in blood and histological examination of the liver. This 
work represents a significant advancement in the tools available to study cellular metabolism and predict drug 
response in living systems.
Results
Sensing mechanism of the two-photon dual imaging probes. This two-photon sensing platform 
consists of three probes (Fig. 1A), which combine a tris(2,2′ -bipyridine)Ru(II) complex as the turn-on fluores-
cent unit, with the specific responsive group for GSH, H2O2 or HOCl, which also serves as an electron acceptor. 
Excitation of the tris(2,2′ -bipyridine)Ru(II) complex leads to the triplet state of metal-to-ligand charge transfer 
(3MLCT), and by this process, the metal electrons are transferred to the bipyridine ligands in an emissive state. 
As shown in Fig. 1B, when this ligand is conjugated to a strong electron acceptor, such as phenyl-2,4dinitroben-
zenesulfonate (phenyl-DNBSO) in the GSH-detection probe (P-GSH), the electron transfer destination will be 
diverted from 2,2′ -bipyridine to phenyl-DNBSO. Thus, the 3MLCT is corrupted and the fluorescence and lifetime 
of the Ru(II) complex are quenched by an intramolecular photo-induced electron transfer (PET) process. While 
the reaction with GSH, H2O2 or HOCl can specifically trigger the quantitative cleavage of the electron acceptor 
group, and the PET process is eliminated, then the fluorescence of the ruthenium complex can be turned on.
In vitro characterization of the two-photon dual imaging probes. We have previously reported 
that the ruthenium complex has a broad single-photon absorption spectrum from 350 to 550 nm17–20. For in vivo 
application of deep-tissue imaging, we first evaluated the two-photon absorption spectrum of these two-photon 
dual imaging probes. Figure 2A shows the two-photon absorption spectrum of P-GSH with a peak at 850 nm, and 
its emission spectrum with a peak at 612 nm. To determine the fluorescence intensity of P-GSH in response to 
GSH, we added GSH in a stepwise manner and measured the fluorescence signal in an emission channel of 515–
620 nm at a two-photon excitation wavelength of 850 nm. The dose-dependent intensity enhancement of P-GSH 
showed good linear relationships in the concentration range from 0 to 10 μ M of GSH, and the maximum inten-
sity was at the concentration of 20 μ M (Fig. 2B). The H2O2 -detection probe (P-HP) and HOCl-detection probe 
(P-HA) have similar excitation and emission spectra to that of P-GSH (Supplementary Fig. 1A and B). Good 
linear correlations can be obtained in the concentration range from 0 to 50 μ M of H2O2 and 0 to 40 μ M of HOCl 
(Supplementary Fig. 1C and D). Because of the differences in specific responsive groups and PET process, the 
P-GSH, P-HP and P-HA have different sensitivity for detection of GSH, H2O2 and HOCl. Metal complex-based 
probes have been reported to be particularly suitable for FLIM imaging because their fluorescence lifetime (typi-
cally more than 50 ns) is much longer than those of tissue (2–3 ns) and most organic dyes (1–5 ns)23. So we further 
measured the fluorescence lifetime of P-GSH in PBS. The P-GSH has a characteristic 38-fold increase of emission 
lifetime from 6 to 225 ns in the presence of GSH (Fig. 2C and D). P-HP and P-HA also have over 20-fold increase 
of emission lifetime from 5.5 and 4.3 ns to 146 and 90.5 ns, respectively. The optical characteristics of P-GSH, 
P-HP and P-HA are summarized in Supplementary Table. 1.
We have previously reported the specificity and in vitro cellular uptake properties of these probes17–20. To 
further examine their applicability for detecting cellular GSH and ROS levels using FLIM, probes (30 μ M) were 
incubated with a mouse hepatocyte cell line (AML12) in culture media for 2 h. Figure 2E displays the spatial dis-
tribution of the fluorescence lifetime signal of P-GSH in the AML12 cells in two emission channels. According to 
our previous work, long-lifetime fluorescent probes can be differentiated in vivo using the slow decay lifetime τ 2, 
rather than the fast decay lifetime τ 124. Thus, in this study, the pseudo-color was based on the slow decay lifetime 
(τ 2) of individual pixel. In the 350–450 nm spectral channel (left), the fluorescence signal mainly comes from 
nicotinamide adenine dinucleotide phosphate (NAD(P)H), which is a major endogenous fluorophore in cells. 
The spectral channel of 515–620 nm (right) captured the fluorescence signal of P-GSH, as well as aufluorescence 
signal from flavin adenine dinucleotide (FAD) in cells. Characteristic longer slow decay lifetimes (> 100 ns) could 
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be detected within the cells after P-GSH administration in the 515–620 nm spectral channel. While no such 
long lifetime was observed after cells incubated with a thiol scavenger, N-ethylmaleimide (NEM), to remove 
the endogenous GSH. Because reacted probe has much longer lifetime compared to unreacted probe and FAD, 
we believe the significant increase of τ 2 with the cells after probe administration is due to the reaction of probe 
and their specific substrate. These results confirm that the cellular lifetime change is attributed to the reaction of 
P-GSH with endogenous intracellular GSH.
To investigate the photostability of P-GSH, P-HP and P-HA for in vivo imaging, we next incubated these 
probes in PBS, GSH, H2O2 or HOCl under irradiation with a deuterium lamp at room temperature, whilst fluo-
rescence intensity and fluorescence lifetime was assessed over time. There was no significant change in the fluo-
rescence intensity (Supplementary Fig. 2) or fluorescence lifetime during the 2 hour irradiation. Thus, our dual 
imaging probes exhibit characteristic long emission lifetime with two-photon excitation and high photostability 
required for detecting GSH or ROS levels in pathophysiological conditions in vivo.
Imaging of cellular oxidative stress in APAP-induced liver injury. The mechanism of APAP-induced 
liver injury is well established. An overdose of APAP can lead to oxidative stress through the overproduction 
of ROS (mainly H2O2). This results in the consumption of key cellular antioxidants, such as GSH, initiating a 
Figure 1. Design of two-photon sensing platform for imaging of oxidative stress. (A) Illustration of 
the sensing mechanism. This sensing platform consists of two parts: a ruthenium complex as the turn-on 
fluorescent unit, and a responsive group as the GSH, H2O2 or HOCl reaction moiety. (B) Response reaction of 
P-GSH, P-HP and P-HA toward GSH, H2O2 or HOCl, respectively. The probes are non-fluorescent due to the 
effective photo-induced electron transfer process (PET). In the presence of GSH, H2O2 or HOCl, the responsive 
group can be quantitatively cleaved, and the reaction ruthenium complex will become highly fluorescent. The 
protonation state of P-HP depends on the organelle pH values. The counter-ions are sodium and potassium in 
biological conditions.
www.nature.com/scientificreports/
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signaling cascade that results in necrotic cell death. GSH and the GSH precursor N-acetylcysteine (NAC) 
can scavenge the reactive metabolites, and have been used to treat patients with APAP overdose25,26. Thus 
APAP-induced liver injury serves as an ideal model of investigating the potential of cellular oxidative stress for 
early prediction of treatment response in a clinically relevant model.
We anesthetized the mice and exposed the liver at 60 min after APAP administration. Fluorescence inten-
sity imaging and FLIM were acquired at 15 min after injection of 50 μ M of P-GSH or P-HP into the portal vein 
(Supplementary Fig. 3). As shown in Fig. 3A, signals induced by the probes response to GSH in cells were clearly 
observed using both fluorescence intensity imaging and FLIM methods. A significant increase in P-GSH fluo-
rescence was observed in some hepatocytes (circled in white). Further analysis of FLIM data reveals a significant 
increase (> 100 ns) in the slow decay lifetime of this area after injection of P-GSH, which is responsible for the 
change of lifetime after reacting with GSH (Fig. 3B and C). Some false-positive hepatocytes determined by flu-
orescence intensity imaging (circled in yellow in Fig. 3A) were found with shorter fluorescence lifetime using 
FLIM, which removes all the possibilities of crosstalk from in vivo environmental or instrumental factors. There 
was no significant decrease of probe signals for up to 2 hours after injection. We then compared P-GSH to bro-
mobimane, a fluorescent heterocyclic compound commonly used for GSH sensing27,28. The fluorescence signal 
produced by bromobimane cannot be differentiated from the liver autofluorescence in vivo after intraportal injec-
tion. Comparable fluorescence intensity imaging of GSH can only be obtained from liver sections treated with 
bromobimane (Supplementary Fig. 4). The percentage of GSH-positive hepatocytes has no significant difference 
between this detection method and FLIM (Supplementary Table 2, p > 0.05). Thus these ex vivo imaging results 
using bromobimane confirmed the in vivo results using P-GSH. While the photochemical characteristics of bro-
mobimane based imaging restrict its utility to ex vivo tissue in contrast to in vivo P-GSH imaging of the GSH 
generation in the liver injury.
Having quantified the cellular oxidative stress response following APAP-induced liver injury, we next eval-
uated the therapeutic context. As shown in Supplementary Fig. 5, zonal GSH changes in the liver during NAC 
treatment were identified in fluorescence intensity images and FLIM at low magnification. Representative 
dual-mode images of GSH and H2O2 at high magnification (Fig. 4A and B) demonstrate the high-resolution 
capability of this technique, which allows single-cell analysis (Supplementary Fig. 6) and population modeling for 
quantification of cellular subpopulations with varying oxidative stress. Calculated from FLIM images, we found 
that NAC treatment significantly increased the percentage of GSH-positive hepatocytes, and decreased that of 
H2O2-positive hepatocytes, compared with the untreated (p < 0.05, Fig. 4C and E). Population density modeling 
of cellular distributions of the GSH intensity calculated from fluorescence intensity images revealed two popula-
tions of GSH-positive hepatocytes at 75 min after APAP administration, both lower than the mean intensity of the 
controls (Fig. 4D). The NAC treated group has a single population with higher fluorescence intensity maxima at 
30 min after NAC administration. This heterogeneity of cellular GSH level was not seen after NAC treatment, sug-
gesting that the APAP sensitive cell subpopulation responses to NAC treatment. The comparison of H2O2 inten-
sity determined on a per cell basis showed similar distributions between groups as to GSH intensity (Fig. 4F).
A composite endpoint, the optical oxidative stress index (OSI), was computed as the ratio of the mean inten-
sity of cellular ROS to the mean intensity of cellular GSH29. After 30 min of NAC treatment, the optical OSI 
was significantly reduced compared with the untreated (p < 0.05, Fig. 5A). By 2 hours, the optical OSI further 
Figure 2. Spectral characterization of P-GSH in vitro. (A) Two-photon absorption and emission spectra 
of P-GSH reacted with 10 μ M of GSH in PBS buffer. (B) Fluorescence response of P-GSH (10 μ M) to varying 
concentrations of GSH. (C) Emission decay of P-GSH in PBS buffer. (D) Emission decay of P-GSH in PBS buffer 
with GSH (20 μ M). (E) FLIM images of representative P-GSH loaded AML12 cells with (lower row) or without 
(upper row) NEM treatment. The autofluorescence of NAD(P)H was collected at λ Exc/λ Em: 740/350 to 450 nm. 
The fluorescence signal for probes and FAD was collected at λ Exc/λ Em: 850/515 to 620 nm. Values are the mean 
for n = 5 replicates.
www.nature.com/scientificreports/
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decreased in the treatment group (p < 0.05). The imaging results were compared with conventional biochemical 
and histological assessment. As shown in Fig. 5B, a significant reduction in plasma alanine aminotransferase 
(ALT) levels associated with NAC treatment was first detected 3 hours after therapy. Furthermore, an increase 
beyond control levels was not detected until 2 hour after delivery of APAP. Histological changes were not appar-
ent 30 min after NAC treatment (Fig. 5C). Remediation of APAP-induced hepatocellular necrosis was observed 
in hematoxylin and eosin (H&E) stained sections of liver tissue 3 hours after NAC treatment. The optical OSI 
changes therefore precede the conventional measures such as plasma liver enzyme levels or histological features 
of liver injury. In addition, no obvious necrosis and abnormity were observed in the sections of liver, kidney and 
spleen tissue from the control group (Supplementary Fig. 7), suggesting that the two-photon dual imaging probes 
have no distinct toxicity. Altogether, these results confirm the utility of this sensing platform for monitoring cel-
lular oxidative stress to predict drug response to APAP-induced liver injury in vivo.
Imaging of cellular oxidative stress in hepatic ischemia-reperfusion injury. It is well documented 
that during hepatic I/R injury, ROS (mainly HOCl) are generated by neutrophils and diffuse into hepatocytes, 
causing oxidant stress-mediated injury30. This pathway can be inhibited by administration of GSH or NAC31. 
Therefore, we used a mouse hepatic I/R injury as an independent model to test the potential of evaluating cellular 
oxidative stress for early prediction of treatment response. At 30 min after reperfusion, we observed reductions 
in the percentage of HOCl-positive hepatocytes and mean HOCl intensity in both GSH and NAC treated groups 
using P-HA (Fig. 6A–C), indicating successful remediation of cellular ROS. There were differences in treatment 
response between GSH and NAC. Consistent with reports that GSH is inferior to NAC as an antidote to hepatic 
I/R injury31, GSH treatment resulted in production of higher HOCl level compared to the NAC treated group 
though still lower than the untreated group (p < 0.05, Fig. 6B and C). Additionally, GSH and NAC increased 
cellular GSH to the same extent (Supplementary Fig. 8).
The optical OSI significantly decreased in both GSH and NAC treated groups compared with the untreated 
group from 30 min after reperfusion (p < 0.05, Fig. 6D). The difference in optical OSI between GSH and NAC 
treated groups was observed at 2 hours after reperfusion (p < 0.05). However, no difference in ALT levels in 
peripheral blood was detected between the treatment groups within 4 hours after reperfusion (Fig. 6E). As shown 
in Fig. 6F, the drug response predicted by dual-mode quantitative imaging was consistent with reduced hepat-
ocyte necrosis observed in H&E stained sections of liver tissue. The optical OSI changes therefore precede the 
conventional measures such as plasma liver enzyme levels or histological features of hepatic I/R injury. These 
results fully characterize optical OSI and show its potential for monitoring early-drug response in vivo at the 
single-cell level.
Figure 3. Dual-mode in vivo imaging of GSH in hepatocytes of mice after APAP administration. (A) 
Representative fluorescence intensity and FLIM images of mouse liver before and 15 min after probes injection. 
All images were recorded at λ Exc/λ Em: 850/515 to 620 nm. Scale bar: 20 μ m. (B) Sketch to illustrate the 
parameters of the fit procedure of the fluorescence decay curve. Two lifetimes, τ 1 and τ 2 represent the fast and 
slow decay lifetimes. The slow decaying fluorescence accumulates on repeated laser pulsing to create enhanced 
background signal, defined as ‘offset’. (C) Fluorescence decay fit curves of representative area (circled in white) 
before (Blue) and after (Red) P-GSH injection.
www.nature.com/scientificreports/
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Discussion
Oxidative stress contributes to a diverse array of physiological and pathological events in living organisms, but 
there is an insufficient understanding of how its cellular fluxes initiate signaling cascades in living animals in 
stages of health, aging, and disease32. Whereas a growing number of chemical tools have been developed to 
probe redox biology, technologies that can monitor fluctuations in cellular redox environment in living animals 
remain limited. We showed that our transition-metal complex-based sensing platform is capable of simultaneous 
two-photon fluorescence intensity imaging and FLIM, enabling accurate in vivo detection of ROS and GSH at the 
single cell-level resolution. Moreover, the imaging results correlate well with conventional markers of liver injury 
such as liver enzyme levels and histology, which validate the optical OSI as a prodromal imaging biomarker for 
prediction and evaluation of drug efficacy.
Although molecular probes have been widely used in biomedical imaging, most of these studies exclusively 
involve steady-state emission where changes in intensity or emission energy of the probes are used as the imag-
ing signal23. Metal complex-based probes are particularly suitable for lifetime-based imaging in a wide range 
of targets in cells, as they emit from long-lived, triplet-based excited states that are usually efficiently populated 
through the heavy-atom effect. For example, some metal complex-based probes can cross the membrane and 
accumulate in the mitochondria to detect metabolic status in mitochondria of cells33. Ruthenium-based probes 
have been developed for lifetime-based imaging of the cellular DNA, RNA and oxygen levels23,34. Furthermore, 
metal complexes often possess high two-photon absorption cross-sections, making them particularly compat-
ible with two-photon based lifetime microscopy techniques35. In particular, the π -conjugated ligands of our 
metal complex-based probes endow them with two-photon absorption property for in vivo deep-tissue imag-
ing. Moreover, the rapid sensing kinetics and large dynamic range of sensitivity allow our metal complex-based 
probes to detect nanomolar to micromolar levels of ROS and GSH in near–real time. This permits sensitive 
monitoring of cellular oxidative stress levels as a mediator of liver injury. This sensing platform has advantages 
over small-molecule fluorescent-based probes for in vivo ROS or GSH imaging reported to date. Conventional 
emission-based detection methods are influenced by probe concentration and the biomolecular microenviron-
ment10,36,37, or have only been employed under one-photon model9,38. We found metal complex-based probes can 
uniquely overcome current limitations to improve detection accuracy in quantitative visualization of oxidative 
stress by FLIM. In addition, since these probes do not have significant systemic toxicity in animals, they may 
also be applied to study the etiology and pathophysiology of diseases involving oxidative stress. It is also worth 
mentioning that the chief limitation of these probes is their irreversibility. Once all reacted, they will not report 
any more changes of the actual GSH, H2O2 and HOCl concentrations. Therefore, reversible probes such as con-
jugated polymer based phosphorescent nanoparticles will be highly needed in the future for in vivo quantitative 
measurement39. Another limitation of this study is the short measurement time window of FLIM (12.5 ns) in our 
multiphoton microscopy (LaVision and DermaInspect). Although we do have detected significant increases in 
Figure 4. Dual-mode quantitative imaging of the change of oxidative stress in hepatocytes responses to 
NAC treatment against APAP induced liver injury. (A,B) Representative fluorescence intensity and FLIM 
images of cellular GSH or H2O2 of the control, APAP, APAP + NAC groups at 30 min after NAC treatment 
(75 min after APAP administration). All images were recorded at λ Exc/λ Em: 850/515 to 620 nm. Scale bar: 20 μ m.  
(C,E) The percentages of GSH or H2O2-positive hepatocytes of the control, APAP, APAP + NAC groups.  
(D,F) Population density modeling of the mean GSH or H2O2 intensity per cell in control APAP, APAP + NAC 
groups. Values are the mean ± s.d. for n = 5 mice; *p < 0.05, compared with APAP groups; #p < 0.05, compared 
with control group.
www.nature.com/scientificreports/
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the slow decay lifetime within the cells after probe administration, phosphorescence lifetime detection is a much 
better suitable technique to accurately determine the long fluorescence lifetime of the probes.
Current methods of evaluation of drug response are generally based on organ morphology, histological char-
acteristics, and biomarkers in peripheral blood. Molecular changes induced by treatment precede changes in 
morphology or these biomarkers, and may provide proximal endpoints of drug response40. The optical OSI from 
dual-mode images using metal complex-based probes captures these drug-induced changes in GSH and ROS, 
which have been hypothesized to correlate closely with treatment outcomes6,41. Our study introduce the con-
cept of molecular imaging as a tool to study drug response in vivo, and is the first to correlate optical OSI with 
a standard assay of drug response in liver injury. The data presented here support the use of optical OSI as an 
effective imaging biomarker for evaluation of drug response, as cellular H2O2, HOCl and GSH levels change at 
an early stage after liver injury, and precede even histological signs of liver tissue and changes of liver enzymes in 
peripheral blood. Beyond the study of liver injury, optical OSI may also have utility predicting drug response in 
other systems. For example, in neurodegenerative diseases, ROS have been implicated as the initiators of protein 
misfolding and the downstream inducers of cell death42. ROS also have an important role in inflammatory dis-
eases, acting as effectors and signaling molecules in both the innate and adaptive immune response7. ROS levels 
change rapidly during anti-cancer therapy. High levels of ROS generated by chemotherapeutic agents for liver 
cancer, such as doxorubicin, platinum drugs and 5-fluorouracil, can induce cancer cell death43,44. Thus, detection 
Figure 5. Optical oxidative stress index (OSI) of the liver detects response to NAC treatment against 
APAP induced liver injury. (A) Optical OSI of the liver at 30 min and 2 hours after NAC treatment (75 and 
165 min after APAP administration). (B) Concentration-time profile of ALT levels in peripheral blood of the 
APAP and APAP + NAC groups. (C) Representative histology (H&E staining) of the liver of the control, APAP, 
APAP + NAC groups at 30 min and 3 hours after NAC treatment (75 and 225 min after APAP administration). 
Arrows indicate cellular necrosis. Values are the mean ± s.d. for n = 5 mice; *p < 0.05, compared with untreated 
groups; #p < 0.05, compared with control group.
www.nature.com/scientificreports/
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of oxidative stress in real time and with high resolution using metal complex-based probes may help uncover 
mechanisms of ROS production and action in a broad range of diseases and contribute to the development of 
new therapeutics.
High-resolution image analysis revealed initial heterogeneous GSH and ROS levels among hepatocytes after 
APAP-induced injury (Fig. 4D and F). The cellular details of the liver can be imaged deep to 250 μ m below the 
fibrous capsule of Glisson using multiphoton microscopy. According to our previous study, imaging depth of 50 
to 100 μ m was the clearest for observing cellular and subcellular morphology in the liver24,45. Hepatocytes around 
the central vein (Zone 3) are more sensitive to APAP-induced injury than those around the portal vein (Zone 1)46. 
Consistent with this, our data suggest that there exist two intrinsic subpopulations of hepatocytes with differential 
tolerance to APAP toxicity. This heterogeneity of cellular GSH and ROS levels was not seen after NAC treatment, 
suggesting that NAC is protective to this APAP sensitive subpopulation. The ability to detect disease severity at a 
cellular level before treatment may provide leads for identification of drugs that target such susceptible subpopu-
lations before they are selected by the primary therapy.
In conclusion, in this proof-of-concept study using a two-photon sensing platform, we present the first 
dual-mode quantitative imaging of cellular oxidative stress in vivo. The high resolution and high accuracy of 
imaging allows subpopulation analysis for identification of heterogeneous disease severity among cell populations 
and assessment of drug response. We demonstrate that optical OSI can be used as an early and sensitive indicator 
of metabolic response to treatment in two distinct models of liver injury. Altogether, these results suggest that 
two-photon dual imaging probes are a powerful tool to monitor the production and action of cellular oxidative 
stress in a broad range of diseases and inform the rational modification of treatment decisions accordingly.
Methods
Chemicals and cells. All chemicals were obtained from Sigma-Aldrich (St Louis, MO, USA) unless other-
wise stated. Bromobimane was purchased from Santa Cruz (Santa Cruz, California, USA). PBS was purchased 
from Invitrogen (Carlsbad, CA, USA). The P-GSH, P-HP and P-HA were synthesized according to the litera-
ture17–20. AML12 cells were obtained from ATCC (Manassas, VA, USA) and maintained in vitro under cell culture 
conditions recommended by ATCC.
In vitro characterisation. Two-photon absorption spectrum was recorded using DermaInspect system 
(Jen-Lab GmbH, Jena, Germany). The power (15 mW) and laser pulses (80-MHz and 85 fs pulse width) were 
adjusted under the chosen measurement conditions that were kept constant throughout this study. Emission 
spectra were measured on a Perkin-Elmer LS 50B fluorescence spectrometer with excitation and emission slits 
of 10 nm. To determine optical responses of probes toward different GSH, H2O2 and HOCl in solution, the 
fluorescence intensities (λ ex = 850 nm, λ em = 515 to 620 nm) of the P-GSH, P-HP and P-HA (10 μ M) in PBS 
(30 mM, pH = 7.4) were measured 5 min after the addition of GSH, H2O2 and HOCl to determine the intensity 
enhancement. Emission lifetimes were measured on an ISS-Chronos multifrequency cross-correlation phase and 
Figure 6. Quantitative in vivo detection of different responses to GSH and NAC treatment against hepatic 
I/R injury. (A) Representative fluorescence intensity and FLIM images of cellular HOCl of the control, I/R, 
I/R + GSH, and I/R + NAC groups at 30 min after reperfusion. All images were recorded at λ Exc/λ Em: 850/515 
to 620 nm. Scale bar: 20 μ m. (B) The percentages of HOCl-positive hepatocytes in all groups. (C) Population 
density modeling of the mean HOCl intensity per cell in the I/R, I/R + GSH, and I/R + NAC groups. (D) 
Optical OSI of the liver at 30 min and 2 hours after reperfusion. (E) Concentration-time profile of ALT levels in 
peripheral blood of the I/R, I/R + GSH, and I/R + NAC groups. (F) Representative histology (H&E staining) of 
the liver of all groups at 4 hours after reperfusion. Arrows indicate cellular necrosis. Values are the mean ± s.d. 
for n = 5 mice; *p < 0.05, compared with untreated groups; #p < 0.05, compared with I/R + GSH group.
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modulation lifetime spectrometer (ISS Inc., Champaign, IL, USA). For examining the applicability of probes 
for detecting cellular GSH and ROS levels using FLIM imaging, 1 × 105 AML12 cells per well were plated in 12 
well plates and incubated for 24 h at 37 °C and 5% CO2. To remove the intracellular GSH, cells were incubated 
in serum free medium containing N-ethylmaleimide (100 μ M) for 1 h at 37 °C in the incubator. Cells were then 
exposed to 30 mM of P-GSH in serum free medium and incubated for 2 h in the same conditions. To investigate 
the photostability of P-GSH, P-HP and P-HA, these probes were incubated in PBS, GSH, H2O2 or HOCl under 
irradiation with a 30 W deuterium lamp (one-photon spectrum: 85 to 400 nm) at room temperature. Fluorescence 
intensity and FLIM imaging was performed using DermaInspect system (Jen-Lab GmbH, Jena, Germany) 
equipped with an ultrashort (85 fs pulse width) pulsed mode-locked 80-MHz titanium sapphire laser (MaiTai, 
Spectra Physics, Mount View, CA, USA) and a time-correlated single-photon counting (TCSPC) SPC-830 detec-
tor (Becker & Hickl, Berlin, Germany). The excitation wavelength was set to 740 nm for autofluorescence and 
850 nm for probe signals, with emission signal ranges of 350 to 450 nm and 515 to 620 nm established respectively 
through the use of BG39 bandpass filters (BG39, Schott glass color filter, Schott MG, Mainz, Germany). Images 
were recorded with oil-immersion × 40 objectives (Carl Zeiss, Oberkochen, Germany). The laser power was set 
to 15 mW for × 40 magnification imaging, and the acquisition time for obtaining the images was 7.4 seconds per 
frame. Fluorescence emission was spectrally resolved between linearly arranged photon counters through the use 
of dichroic filters in the beam path.
Animal models. Male 8-week-old BALB/c mice were purchased from the Animal Resource Centre (Perth, 
Western Australia). All animal procedures were approved by the Animal Ethics Committee of the University 
of Queensland and were carried out in accordance with Australian Code for the Care and Use of Animals for 
Scientific Purposes 8th edition. For APAP-induced liver injury, mice received gavage of 500 mg/kg APAP in 0.9% 
saline. Liver ischemia-reperfusion injury was induced by clamping the portal vein and hepatic artery supplying 
the median and left lobes using a microvascular clamp. After 45 min of partial ischemia, the clamp was removed 
to allow reperfusion in the liver. For drug efficacy studies, animals were treated with 150 mg/kg of NAC intrave-
nously 45 min after APAP administration2, and 200 mg/kg of GSH or 150 mg/kg of NAC intravenously 45 min 
before liver ischemia47.
In vivo imaging of GSH and ROS. Mice were anaesthetized initially by the intraperitoneal injection of ket-
amine hydrochloride (80 mg/kg) and xylazine (10 mg/kg). Body temperature was controlled by placing mice on a 
heating pad set to 37 °C. Intravital imaging of the mouse liver was performed as previously described24,45. Briefly, 
a midline laparotomy is performed and the liver is exposed for imaging. The left lobe of the liver is placed on the 
metal plate, which was slightly raised above the intraperitoneal cavity to minimize pressure on the organs under-
neath. Normal saline was used to keep the liver moist and attached to the cover glass throughout the experiment. 
50 μ M of probe suspended in 0.2 mL PBS was injected with a 27 gauge needle into the portal vein.
Multiphoton imaging was performed using the Lavision Biotec Nikon multiphoton microscopy (LaVision 
BioTec, Bielefeld, Germany) and DermaInspect system (Jen-Lab GmbH, Jena, Germany) equipped with an ultra-
short (85 fs pulse width) pulsed mode-locked 80-MHz titanium sapphire laser (MaiTai, Spectra Physics, Mount 
View, CA, USA). The excitation wavelength was set to 740 nm for organ autofluorescence and 850 nm for probe 
signals, with emission signal ranges of 350 to 450 nm and 515 to 620 nm established respectively through the use 
of BG39 bandpass filters (BG39, Schott glass color filter, Schott MG, Mainz, Germany). Images were recorded 
with water-immersion × 10 or oil-immersion × 40 objectives (Carl Zeiss, Oberkochen, Germany). The laser 
power was set to 20 or 15 mW for × 10 or × 40 magnification imaging, and the acquisition time for obtaining 
the images was 7.4 seconds per frame. For FLIM, a time-correlated single-photon counting (TCSPC) SPC-830 
detector (Becker & Hickl, Berlin, Germany) was incorporated into the DermaInspect system. The TCSPC module 
constructs a photon distribution across the x and y coordinates of the scan area. Fluorescence emission was spec-
trally resolved between linearly arranged photon counters through the use of dichroic filters in the beam path. The 
emission light was collected spectrally in a channel from 515 to 620 nm at 850-nm excitation. Imaging depth of 50 
to 100 μ m below the fibrous capsule of Glisson were chosen and kept constant throughout this study. Twenty-four 
images from twelve non-overlapping fields were collected per mouse (n = 5) without the use of randomization 
and blinding.
FLIM images were analysed using SPCImage software 4.9.7 (Becker & Hickl, Berlin, Germany). The fluo-
rescence intensity decay curve of each pixel was fitted to a bi-exponential decay model: F(t) = α 1e−t/τ1 + α 2e−t/τ2 
+ C. Two lifetimes, τ 1 and τ 2 represent the fast and slow decay lifetimes; α 1 and α 2 are the corresponding relative 
amplitude coefficients, where α 1 + α 2 = 1. C is a constant related to the level of background light present and 
the contribution from all preceding excitation pulses (the ‘offset’-signals)24,48. The values of τ 1, τ 2, α 1, α 2 and 
C were obtained from the fitting. When excited by laser pulses with an 80 MHz repetition rate, the slow decay 
fluorescence of the long-lifetime fluorescent probes for hundreds of excitation pulses accumulates and forms a 
quasi-continuous background. This background is significantly larger than the background caused by possible 
incomplete decay of endogenous fluorescence. The ‘offset’-signals of reacted probes and the cellular autofluo-
rescence (‘offset’ parameter within BH SPCImage determines the baseline of the fluorescence decay curve) were 
adjusted under the chosen measurement conditions that were kept constant throughout this study. Since the 
fluorescence decay of reacted probes is slow compared to the measurement time window which is defined by 
the repetition rate of the laser system, the “Incomplete Model” in SPCImage software was used for calculation 
according to the software handbook.
Single-cell analysis of images. The cellular-level image analysis was done using ImageJ 1.44p (National 
Institutes of Health, USA) and Cell Profiler 2.1.0 in Matlab R2015a (The MathWorks Inc.). Grayscale FLIM 
images were imported and cell pixels were smoothed. The resulting round objects between 30 and 70 pixels in 
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diameter were segmented and saved as the cell within the image. An Otsu Global threshold was used to improve 
propagation and prevent propagation into background pixels. Then corresponding fluorescence intensity images 
were imported. Subpopulation analysis was performed by generating histograms of all cell values from fluores-
cence intensity images of positive cells identified by FLIM images. Each histogram was fitted to 1 and 2 compo-
nent Gaussian curves. The lowest Akaike information criterion (AIC) signified the best fitting probability density 
function for the histogram. Probability density functions were normalized to have an area under the curve equal 
to 1. The OSI was calculated as the ratio of the mean intensity of cellular ROS to the mean intensity of cellular 
GSH.
Tissue collection and plasma biochemical measurements. Mouse blood (0.2 mL) was collected in 
lithium heparin tubes from the inferior vena cava using a 30 gauge needle. At the end of the experiment, the 
liver, kidney and spleen were excised, and portions were immersed into 10% buffered formalin for histological 
assessment. Plasma concentration of alanine aminotransferase (ALT) was measured using a Hitachi 747 analyzer 
(Hitachi Ltd., Tokyo, Japan).
Histology. Organ specimens were fixed in 4% buffered formalin and embedded in paraffin. Sections were 
obtained for Hematoxylin & Eosin (H&E) stain to evaluate histopathologic features. The OlyVIA software 2.6 
(Olympus, Münster, Germany) was used to visualise and scan the slides. Bromobimane was used for labelling 
GSH in liver sections on slides according to the manufacturer instructions.
Statistical tests. Student’s t test with a Bonferroni correction was used to compare the data between groups. 
All the statistical analysis was done using GraphPad Prism v 6.04 (GraphPad Software Inc., La Jolla, California). 
Results were considered statistically significant with a p-value < 0.05.
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